{"id":"W2619562612","doi":"10.1016/s2213-2600(17)30190-x","title":"Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Vancouver General Hospital; University of British Columbia","funders":"AstraZeneca","keywords":"Medicine; Benralizumab; Asthma; Placebo; Internal medicine; Dry-powder inhaler; Eosinophil; Inhaler; Mepolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001400706,0.0005606587,0.002029733,0.0002081641,0.001171367,0.0001119793,0.0007198577,0.0001675935,0.0001999727],"category_scores_gemma":[0.001018094,0.0002782372,0.0004752885,0.0001374463,0.0005535713,0.0001824081,0.000105942,0.000364359,0.0000359834],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001284571,"about_ca_system_score_gemma":0.0003960183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002980677,"about_ca_topic_score_gemma":0.00003681756,"domain_scores_codex":[0.9965076,0.0001932431,0.0008222293,0.0006925643,0.0009800323,0.0008042635],"domain_scores_gemma":[0.9958392,0.000335553,0.0006118345,0.001906205,0.0005794998,0.0007277402],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9745939,0.0008318712,0.0004482489,0.0001376099,0.0005299483,0.00003614947,0.0003513224,0.00006069599,0.00009664451,0.00009420426,0.01679097,0.006028402],"study_design_scores_gemma":[0.902473,0.01726813,0.0007814661,0.0004425327,0.0009573483,0.000005529655,0.0001933552,0.0001827249,0.0001222229,0.00001518677,0.07722193,0.0003366013],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9667691,0.00110708,0.0003067639,0.007528976,0.0007653889,0.01753094,0.00009128291,0.0001205653,0.005779886],"genre_scores_gemma":[0.982452,0.00002005097,0.0001092458,0.0065632,0.006397254,0.00316559,0.00006972995,0.00009788947,0.001125042],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07212096,"threshold_uncertainty_score":0.999967,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08581923633290346,"score_gpt":0.3646516423486015,"score_spread":0.278832406015698,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}